BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9927991)

  • 1. Signaling by the cytokine receptor superfamily.
    Ihle JN; Thierfelder W; Teglund S; Stravopodis D; Wang D; Feng J; Parganas E
    Ann N Y Acad Sci; 1998 Dec; 865():1-9. PubMed ID: 9927991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jaks and Stats in signaling by the cytokine receptor superfamily.
    Ihle JN; Kerr IM
    Trends Genet; 1995 Feb; 11(2):69-74. PubMed ID: 7716810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling by the cytokine receptor superfamily: JAKs and STATs.
    Ihle JN; Witthuhn BA; Quelle FW; Yamamoto K; Thierfelder WE; Kreider B; Silvennoinen O
    Trends Biochem Sci; 1994 May; 19(5):222-7. PubMed ID: 8048164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokine signaling].
    Chida D; Miyajima A
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1525-31. PubMed ID: 9279077
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of Jak kinases and STATs in cytokine signal transduction.
    Leonard WJ
    Int J Hematol; 2001 Apr; 73(3):271-7. PubMed ID: 11345192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistochemical localization of signal-transduction pathway components Jak1, Jak2, Jak3, Tyk2 and STAT-1 during early enamel and dentine formation in rat molars.
    Tanase S; Bawden JW
    Arch Oral Biol; 1996 Oct; 41(10):925-40. PubMed ID: 9031700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
    Nosaka T; Kitamura T
    Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinases in cytokine signalling.
    Ihle JN
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):159-66. PubMed ID: 8650262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Jak-Stat pathway in normal and perturbed hematopoiesis.
    Ward AC; Touw I; Yoshimura A
    Blood; 2000 Jan; 95(1):19-29. PubMed ID: 10607680
    [No Abstract]   [Full Text] [Related]  

  • 11. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
    Li WQ; Dehnade F; Zafarullah M
    J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jaks and Stats in cytokine signaling.
    Ihle JN; Nosaka T; Thierfelder W; Quelle FW; Shimoda K
    Stem Cells; 1997; 15 Suppl 1():105-11; discussion 112. PubMed ID: 9368330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the JAK-STAT system in signal transduction via cytokine receptors.
    Watanabe S; Arai Ki
    Curr Opin Genet Dev; 1996 Oct; 6(5):587-96. PubMed ID: 8939729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway.
    Dorsch M; Fan PD; Danial NN; Rothman PB; Goff SP
    J Exp Med; 1997 Dec; 186(12):1947-55. PubMed ID: 9396763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and STAT signaling.
    Schindler C; Strehlow I
    Adv Pharmacol; 2000; 47():113-74. PubMed ID: 10582086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.